Ustekinumab for successful treatment of refractory esophageal crohn's disease

Jodie A. Barkin, Amar R. Deshpande

Research output: Contribution to journalArticle

Abstract

Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.

Original languageEnglish (US)
Pages (from-to)107-108
Number of pages2
JournalACG Case Reports Journal
Volume3
Issue number2
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this